Edwards Lifesciences EW
NYSE EW
$86.16 -0.56 (-0.65%)
As of: Sep 9, 2026 · 3:59 PM EDT

Edwards Lifesciences (EW) Operating Income Growth (3y) (2012 - 2026)

Analysis

Edwards Lifesciences (EW) Operating Income Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (3y) (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 3.16%
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 28.02%
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 11.63%
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 19.80%
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 31.84%
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 24.88%
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -65.59%
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 35.44%
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 13.06%
10 Zimmer Biomet Holdings 18.20 Bn 17.79 Bn 1.54 Bn -0.36%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 24.88%
Mar 31, 2026 7.13%
Dec 31, 2025 -8.57%
Sep 30, 2025 -8.62%
Jun 30, 2025 -3.63%
Mar 31, 2025 -3.46%
Dec 31, 2024 -5.84%
Sep 30, 2024 -3.51%
Jun 30, 2024 -12.23%
Mar 31, 2024 -3.09%
Dec 31, 2023 -0.44%
Sep 30, 2023 0.75%
Jun 30, 2023 52.59%
Mar 31, 2023 2.74%
Dec 31, 2022 -14.00%
Sep 30, 2022 10.99%
Jun 30, 2022 19.76%
Mar 31, 2022 16.97%
Dec 31, 2021 317.25%
Sep 30, 2021 16.18%